Pro MedicusASX:PME +3.50%98 Dividend Yield % is 0.36% as of Jun. 25, 2026, which is 20% above its 10-year median of 0.30. GuruFocus rates ASX:PME with a GF Score™ of 98/100 and a GF Value™ of A$244.95 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 279 Healthcare Providers & Services companies, Pro Medicus ranks worse than 93.19% on this metric.
As of today (2026-06-25), the Trailing Annual Dividend Yield of Pro Medicus is 0.36%.
The historical rank and industry rank for Pro Medicus's Dividend Yield % or its related term are showing as below:
ASX:PME'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.12 Med: 0.3 Max: 0.64
Current: 0.36
During the past 13 years, the highest Dividend Yield of Pro Medicus was 0.64%. The lowest was 0.12%. And the median was 0.30%.
ASX:PME's Dividend Yield % is ranked worse than 93.19% of 279
companies
in the Healthcare Providers & Services industry
Industry Median: 2.41
vs ASX:PME: 0.36
During the past 12 months, Pro Medicus's average Dividends Per Share Growth Rate was 37.50% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 37.70% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 36.10% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 38.60% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Pro Medicus was 58.70% per year. The lowest was -52.90% per year. And the median was 30.50% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Pro Medicus (ASX:PME) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
The historical data trend for Pro Medicus's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:PME vs VEEV, BTSG, TEM: Dividend Yield % Comparison
For the Health Information Services subindustry, Pro Medicus's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pro Medicus Dividend Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pro Medicus's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Pro Medicus's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Pro Medicus Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
AUD 0.320000
2026-02-26
2026-02-27
2026-03-20
Cash Dividend
semi-annually
AUD:AUD 1.000000
AUD 0.300000
2025-09-03
2025-09-04
2025-09-25
Cash Dividend
semi-annually
AUD:AUD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Pro Medicus's Trailing Annual Dividend Yield (%) for Today is calculated as
Trailing Annual Dividend Yield
=
Most Recent Full Year Dividend
/
Current Share Price
=
0.62
/
178.99
=
0.35 %
Current Share Price is A$178.99. Pro Medicus's Dividends per Share for the trailing twelve months (TTM) ended in Today is A$0.62.
Pro Medicus's Forward Annual Dividend Yield (%) for Today is calculated as
Forward Annual Dividend Yield
=
Forward Full Year Dividend
/
Current Share Price
=
0.64
/
178.99
=
0.36 %
Current Share Price is A$178.99. Pro Medicus's Dividends per Share for the forward twelve months is calculated as A$0.32 * 2 = A$0.64.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pro Medicus (ASX:PME) has a Dividend Yield % of 0.36% as of Jun. 25, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Pro Medicus and its competitors. This is 20% above median its historical median of 0.30. Over the past decade, Pro Medicus' Dividend Yield % has ranged from 0.12 to 0.64. According to the industry distribution chart, Pro Medicus ranks #260 out of 279 companies in the Healthcare Providers & Services industry, placing it in the top 93.2%.
Is Pro Medicus' Dividend Yield % too high?
Pro Medicus' current Dividend Yield % of 0.36% is 20% above median its 10-year median of 0.30. Over the past 10 years, this metric has ranged from a low of 0.12 to a high of 0.64. The Healthcare Providers & Services industry median Dividend Yield % is 2.41. Pro Medicus' value of 0.36% is 85.1% below this industry median. Based on the distribution chart, Pro Medicus ranks #260 out of 279 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Pro Medicus has a GF Score™ of 98/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pro Medicus' Dividend Yield % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Pro Medicus ranks #260 out of 279 companies for Dividend Yield %. This places Pro Medicus in the lower half of its industry. The industry median Dividend Yield % is 2.41. Pro Medicus' value of 0.36% is 85.1% below this benchmark. Historically, Pro Medicus' own Dividend Yield % has ranged from 0.12 to 0.64 over the past decade. While the company's 10-year median is 0.30 vs. the industry median of 2.41, Pro Medicus has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Healthcare Providers & Services company?
The median Dividend Yield % among Healthcare Providers & Services companies is 2.41, based on 279 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pro Medicus's current Dividend Yield % of 0.36% is 85.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Pro Medicus and its competitors. For the Healthcare Providers & Services industry, the median Dividend Yield % is 2.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pro Medicus's current Dividend Yield % is 0.36%, which is 20% above median its own 10-year median of 0.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pro Medicus stock overvalued right now?
Based on GuruFocus' analysis, Pro Medicus (ASX:PME) is currently considered Modestly Undervalued. The stock's GF Value™ is A$244.95, compared to a current price of A$178.99 — trading 26.9% below its estimated fair value. The current Dividend Yield % is 0.36%, which is 20% above median its 10-year median of 0.30 and 85.1% below the Healthcare Providers & Services industry median of 2.41. Pro Medicus' overall GF Score™ is 98/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Pro Medicus (ASX:PME), the current Dividend Yield % is 0.36% as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pro Medicus (ASX:PME) Overvalued in 2026?
Based on GuruFocus' analysis, Pro Medicus stock appears to be undervalued.
The current stock price of A$178.99 is trading 26.9% below its estimated GF Value™ of A$244.95.
GuruFocus considers Pro Medicus to be Modestly Undervalued.
Key valuation signals for ASX:PME:
Dividend Yield %: 0.36% (20% above median its 10-year median of 0.30)
GF Value™: A$244.95 vs. price of A$178.99 (26.9% below fair value)
Industry Position: 85.1% below the Healthcare Providers & Services median (#260 of 279)
No single metric tells the full story. See the ASX:PME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are US private academic hospitals. In fiscal 2025, Pro Medicus earned 90% of revenue in North America, 8% from Australia, and the remaining 2% in Europe.
98GF Score
Get the complete analysis for ASX:PME
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:PME has been successfully added to your 
